Ingevity to Report Earnings

Summary

Ingevity is expected to report earnings of 74 cents per share on May 5, with quarterly revenue anticipated to drop by 16.1% to $285.467 million compared to $340.1 million last year. Analysts have a ‘buy’ rating with a median target price of $50.50, which is higher than the latest closing price of $35.04.Reuters

Impact Analysis

1. Business Overview Analysis:

• business_model: Ingevity operates through three segments: high-performance chemicals, advanced polymer technologies, and high-performance materials.Stock Star
• market_position: The company is positioned in the chemical manufacturing industry with diverse product offerings.
• recent_events_impact: Recent adjustments in analyst ratings reflect mixed earnings performance over past quarters.Market Beat+ 2

2. Financial Statement Analysis:

• Income Statement:
• Revenue trends show a decrease from $340.1 million to $285.467 million (down 16.1%).Reuters
• Previous earnings exceeded expectations with EPS of 0.95 against the consensus of 0.29, indicating positive performance in some quarters.Market Beat
• Balance Sheet: Limited information available, but indications of asset and equity adjustments.Market Beat
• Cash Flow: Operational cash flows not detailed in current data.
• Financial Ratios:
• Profitability: Recent EPS outperformance suggests strong profitability in certain periods.Market Beat
• Liquidity and Solvency: No specific data provided.

3. Valuation Assessment:

• Based on analyst ratings, the median target price is $50.50, suggesting potential upside from the current price of $35.04.Reuters

Overall, Ingevity’s upcoming earnings report could impact stock valuation positively if expectations are met or exceeded, while past mixed results warrant careful attention to analyst adjustments and industry position.